FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

4372111000001101: Zantac 75 Dissolve tablets (Haleon UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
147101000001116 Zantac 75 Dissolve tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
147121000001111 Zantac 75 Dissolve tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2885621000001110 Zantac 75 Dissolve tablets (Haleon UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2885641000001117 Zantac 75 Dissolve tablets (Haleon UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17947101000001116 Zantac 75 Dissolve effervescent tablets (GlaxoSmithKline) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17947201000001111 Zantac 75 Dissolve effervescent tablets (GlaxoSmithKline) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38399801000001113 Zantac 75 Dissolve tablets (GlaxoSmithKline Consumer Healthcare) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Is a Ranitidine 75mg effervescent tablets sugar free true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has manufactured dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Is a Zantac true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has active ingredient Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has manufactured dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Is pack of False Zantac 75 Dissolve tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has AMP True Zantac 75 Dissolve tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start